Atrium Health Wake Forest Baptist Infectious Disease-High Point — High Point, North Carolina

Atrium Health Wake Forest Baptist Infectious Disease-High Point is a clinical research site located in High Point, North Carolina, United States 27262.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Atrium Health Wake Forest Baptist Infectious Disease-High Point has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Clostridioides Difficile Associated Disease.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in High Point

Browse all research sites in North Carolina · View every site in High Point

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atrium Health Wake Forest Baptist Infectious Disease-High Point?

Atrium Health Wake Forest Baptist Infectious Disease-High Point has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atrium Health Wake Forest Baptist Infectious Disease-High Point conducted?

Atrium Health Wake Forest Baptist Infectious Disease-High Point has 1 clinical trials on record, with 1 currently active. Their work covers Clostridioides Difficile Associated Disease.

Is Atrium Health Wake Forest Baptist Infectious Disease-High Point accredited by Crixeo Clinical Trials?

Atrium Health Wake Forest Baptist Infectious Disease-High Point has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atrium Health Wake Forest Baptist Infectious Disease-High Point?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.